Precision Biosciences (DTIL) Treasury Shares (2018 - 2026)
Precision Biosciences (DTIL) posted quarterly Treasury Shares of $952000.0 for Q1 2026, little changed year-over-year from $952000.0 in Q1 2025, and little changed quarter-over-quarter from $952000.0 in Q4 2025.
Precision Biosciences (DTIL) Treasury Shares (2018 - 2026) Analysis & Trends
Precision Biosciences (DTIL) has reported Treasury Shares for 9 consecutive years, with $952000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Treasury Shares changed 0.0% year-over-year to $952000.0; the TTM figure through Mar 2026 stood at $952000.0 (changed 0.0% YoY), while the FY2025 annual figure was $952000.0, changed 0.0% from the prior year.
- Treasury Shares steadied at $952000.0 in Q1 2026 per DTIL's latest filing, from $952000.0 in the prior quarter.
- Across five years, Treasury Shares topped out at $1.6 million in Q3 2025 and bottomed at $214857.0 in Q4 2023.
- Historically, Treasury Shares has averaged $1.1 million across 4 years, with a median of $1.2 million in 2025.
- On a YoY basis, Treasury Shares climbed as much as 0.0% in 2022 and fell as far as 0.0% in 2022.
- Precision Biosciences' Treasury Shares stood at $952000.0 in 2022, then changed by 0.0% to $952000.0 in 2023, then changed by 0.0% to $952000.0 in 2024, then changed by 0.0% to $952000.0 in 2025, then changed by 0.0% to $952000.0 in 2026.
- Business Quant data shows DTIL's Treasury Shares at $952000.0 in Q1 2026, $952000.0 in Q4 2025, and $952000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 8.96 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 2.72 Mn |
| 10 | Precision Biosciences | 228.31 Mn | 140.77 Mn | - | 952,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.91 Mn |
| Jun 30, 2026 | 2.91 Mn |
| Jun 30, 2026 | 952,000.00 |
| Jun 30, 2026 | 952,000.00 |
| Mar 31, 2026 | 1.00 Mn |
| Mar 31, 2026 | 1.00 Mn |
| Mar 31, 2026 | 952,000.00 |
| Mar 31, 2026 | 952,000.00 |
| Dec 31, 2025 | 1.62 Mn |
| Dec 31, 2025 | 1.62 Mn |
| Dec 31, 2025 | 952,000.00 |
| Dec 31, 2025 | 952,000.00 |
| Sep 30, 2025 | 952,000.00 |
| Sep 30, 2025 | 1.63 Mn |
| Sep 30, 2025 | 1.63 Mn |
| Sep 30, 2025 | 952,000.00 |
| Jun 30, 2025 | 1.33 Mn |
| Jun 30, 2025 | 952,000.00 |
| Jun 30, 2025 | 952,000.00 |
| Jun 30, 2025 | 1.33 Mn |